文献速递中毒与环境急症

从蘑菇中毒患者呕吐物标本中分子鉴定出井口毒鹅膏

Molecular identification of Amanita ibotengutake from patient vomit specimens in mushroom poisoning.
PubMed 文献 · Clin Toxicol (Phila) · 2025-09-15
一句话结论单例蘑菇中毒患者摄入后7小时呕吐物PCR扩增成功,分子鉴定为井口毒鹅膏(Amanita ibotengutake),推翻形态学鉴定的豹斑鹅膏,提示呕吐物分子鉴定在临床可行。

研究报道日本山形县2018年9月一起蘑菇中毒事件中一名女性患者,采集4份呕吐物标本,对其中3份进行内转录间隔区PCR扩增测序,全部4份进行液相色谱-串联质谱毒素定量。摄入后7小时采集的3份呕吐物成功扩增185碱基对目标序列,序列同源性100%鉴定为井口毒鹅膏(Amanita ibotengutake),与初始形态学鉴定的豹斑鹅膏(Amanita pantherina)不符。液相色谱-串联质谱在呕吐物中检出总0.053 mg鹅膏蕈氨酸和0.0043 mg蝇蕈醇,与患者神经系统症状一致。作者认为该分子-毒理学整合方法可能有助于加强蘑菇中毒文献报告、理解物种特异性毒性,但限于单例,需在更多病例中进一步验证。

要点

  • 摄入后7小时采集的3份呕吐物标本均成功PCR扩增185 bp目标序列,序列一致,同源性100%鉴定为井口毒鹅膏。
  • 分子鉴定(井口毒鹅膏)与初始形态学鉴定(豹斑鹅膏)不一致,两物种直至2002年才被认为相同。
  • 呕吐物液相色谱-串联质谱检出总0.053 mg鹅膏蕈氨酸和0.0043 mg蝇蕈醇,与患者神经系统症状一致。
  • 尽管胃内降解带来技术挑战,摄入后7小时呕吐物DNA扩增成功,提示临床可行性。
  • 作者认为该分子-毒理学整合方法可能有助于理解物种特异性毒性并改善蘑菇中毒流行病学调查,但限于单例,需更多病例验证。

适用人群与场景

  • 日本山形县2018年9月一起蘑菇中毒事件中的一名女性患者。

研究设计与关键结果

  • 研究类型为病例报告(单例),采集4份呕吐物标本,对其中3份进行内转录间隔区PCR扩增测序,全部4份进行液相色谱-串联质谱或毒素定量。
  • 摄入后7小时采集的3份呕吐物标本成功扩增185碱基对目标序列,序列一致,同源性100%鉴定为井口毒鹅膏(Amanita ibotengutake),与初始形态学鉴定的豹斑鹅膏(Amanita pantherina)不符。
  • 液相色谱-串联质谱在呕吐物中检出总0.053 mg鹅膏蕈氨酸和0.0043 mg蝇蕈醇,与患者神经系统症状一致。

证据类型、等级与局限

  • 证据类型:病例报告(单例)。
  • 作者指出形态学鉴定准确率限于17%。
  • 局限:限于单例;需在更多病例中进一步验证以扩大科学应用。

对床旁实践的改变

  • 作者认为该分子-毒理学整合方法可能有助于加强蘑菇中毒文献报告、理解物种特异性毒性并改善流行病学调查。
  • 作者指出形态学与分子鉴定不一致显示常规方法的局限性,尤其两物种直至2002年才被认为相同。
  • 作者指出摄入后7小时呕吐物DNA扩增成功,尽管胃内降解带来技术挑战,提示临床可行性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Mushroom poisoning remains a global public health challenge, with morphological identification accuracy limited to 17%. This study aimed to demonstrate molecular identification from vomit specimens in a patient with mushroom poisoning.

METHODS: Following a mushroom poisoning incident in Yamagata Prefecture, Japan (September 2018), we collected four vomit specimens from a female patient. Deoxyribonucleic acid analysis targeting the internal transcribed spacer region using polymerase chain reaction and sequencing was performed on three of four specimens, while liquid chromatography-tandem mass spectrometry or toxin quantification was conducted on all four specimens. Species identification was conducted through sequence homology analysis.

RESULTS: Polymerase chain reaction amplification of the 185 base pair target sequence was successful from three vomit specimens collected 7 h post-ingestion, yielding identical sequences. Sequence analysis identified Amanita ibotengutake (100% homology), contradicting the initial morphological identification of Amanita pantherina. Liquid chromatography-tandem mass spectrometry detected a total of 0.053 mg ibotenic acid and 0.0043 mg muscimol in vomit specimens, consistent with the patient's neurological symptoms.

DISCUSSIONS: The discrepancy between morphological (Amanita pantherina) and molecular (Amanita ibotengutake) identification demonstrates limitations of conventional methods, particularly significant as these species were considered identical until 2002. Successful deoxyribonucleic acid amplification 7 h post-ingestion, despite technical challenges from gastric degradation, suggests clinical feasibility. This integrated molecular-toxicological approach strengthens scientific understanding of species-specific toxicities and contributes to improved epidemiological investigation of mushroom poisoning.

CONCLUSIONS: We report the successful molecular identification from patient vomit specimens in a patient with mushroom poisoning. Although limited to a single case, this methodology may contribute to strengthening mushroom poisoning reports in the scientific literature to improve understanding of species-specific toxicities. Further validation in additional cases is needed for broader scientific applications.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Ota K, Taira K, Ito I, et al. Molecular identification of Amanita ibotengutake from patient vomit specimens in mushroom poisoning. Clin Toxicol (Phila). 2025. PMID: 40948393. doi:10.1080/15563650.2025.2551835

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。